	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	1,711	1,815	1,896	1,948	1,995	2,070	2,455	3,161	2,725	2,429	3,759	4,517	3,807	4,073	4,358	4,498
Cost of Operating Revenue	1,193	1,236	1,383	1,463	1,419	1,337	1,390	1,722	1,787	1,717	2,347	3,029	3,371	3,363	3,384	3,399
Gross Profit	518	579	513	485	576	733	1,064	1,440	938	712	1,412	1,488	436	710	974	1,098
Gross Margin	30.3	31.9	27.0	24.9	28.9	35.4	43.4	45.5	34.4	29.3	37.6	32.9	11.4	17.4	22.3	24.4
Total Operating Expenses	1,459	1,471	1,673	1,772	1,768	1,732	1,795	2,182	2,302	2,245	2,970	3,678	4,041	4,095	4,367	4,403
Operating Profit	252	344	223	176	228	339	659	979	423	184	789	839	-234	-22	-9	95
Operating Margin	14.7	19.0	11.8	9.0	11.4	16.4	26.9	31.0	15.5	7.6	21.0	18.6	-6.2	-0.5	-0.2	2.1
Financing Income/(Expense) - Net	-9	10	24	31	36	39	42	35	52	29	24	14	24	-9	-63	-66
Profit before Taxes	223	337	247	215	262	381	749	1,016	491	235	826	695	-300	-71	21	144
Income Taxes	70	101	62	-12	43	73	215	326	159	69	267	285	-64	-6	23	78
Profit after Tax	154	235	185	228	220	307	534	690	332	166	560	410	-237	-65	-2	66
PAT Margin	9.0	13.0	9.8	11.7	11.0	14.8	21.8	21.8	12.2	6.8	14.9	9.1	-6.2	-1.6	-0.1	1.5
EPS - Basic - ex Extraordinary Items	20.92	32.05	25.20	31.03	29.90	41.85	72.78	93.98	45.22	22.57	76.22	55.78	-32.25	-8.87	-0.33	9.04
EPS - Diluted - ex Extraordinary Items	20.92	32.05	25.20	31.03	29.90	41.85	72.78	93.98	45.22	22.57	76.22	55.78	-32.25	-8.87	-0.33	9.04
EBIT	252	344	223	176	228	339	659	979	423	184	789	839	-234	-22	-9	95
EBITDA	403	496	374	274	335	450	787	1,119	584	358	987	1,115	143	370	405	510
EBITDA Margin	23.6	27.3	19.7	14.1	16.8	21.7	32.1	35.4	21.4	14.8	26.2	24.7	3.8	9.1	9.3	11.3

Balance Sheet

Abridged

Understanding Balance Sheet

Gujarat Alkalies And Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	R 2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	889	894	802	823	896	1,013	1,275	1,610	1,372	1,089	1,094	1,410	913	1,055	1,180
Long-Term Investments	158	170	180	191	866	1,023	1,013	847	905	1,654	1,703	1,590	1,935	1,654	1,434
Property Plant & Equipment - Net	1,643	1,764	1,645	1,723	1,900	2,217	2,349	2,601	3,049	3,691	4,485	4,790	4,710	4,662	4,466
Total Non-Current Assets	1,936	2,010	2,030	2,165	2,998	3,423	3,695	3,921	4,521	6,069	6,883	6,925	7,110	6,932	6,353
Total Assets	2,826	2,904	2,831	2,988	3,894	4,435	4,970	5,531	5,893	7,157	7,977	8,335	8,023	7,987	7,533
Total Current Liabilities	611	500	330	388	348	409	478	508	528	611	735	840	745	933	993
Long Term Debt	237	195	152	92	222	284	230	185	138	434	550	460	343	317	246
Total Non-Current Liabilities	606	591	537	464	618	671	671	727	767	1,168	1,343	1,356	1,203	1,384	1,348
Total Liabilities	1,218	1,091	868	851	966	1,080	1,149	1,235	1,295	1,780	2,078	2,196	1,948	2,317	2,342
Total Shareholders' Equity	1,608	1,813	1,964	2,137	2,928	3,356	3,821	4,296	4,598	5,378	5,899	6,139	6,076	5,670	5,191
Total Equity	1,608	1,813	1,964	2,137	2,928	3,356	3,821	4,296	4,598	5,378	5,899	6,139	6,076	5,670	5,191
Total Liabilities & Equity	2,826	2,904	2,831	2,988	3,894	4,435	4,970	5,531	5,893	7,157	7,977	8,335	8,023	7,987	7,533

Cash Flow

Abridged

Understanding Cash Flow Statement

Gujarat Alkalies And Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	319	416	318	235	326	405	693	912	610	401	740	966	129	480	527
Working Capital - Increase/(Decrease)	19	16	-54	76	-87	129	-142	-39	73	82	28	14	-41	-90	-113
Net CF from Operating Activities	339	433	264	311	239	534	551	873	683	483	768	979	87	390	413
Capital Expenditures - Net	228	225	86	200	285	439	284	387	574	791	908	683	230	322	258
Net CF from Investing Activities	-235	-236	-196	-238	-398	-511	-447	-639	-702	-403	-844	-699	-156	-315	-277
Dividends Paid - Cash - Total	26	26	30	34	40	40	44	58	71	59	59	74	173	102	116
Debt - LT & ST - Issuance/(Retirement) - Total	-37	-77	-53	-44	133	66	-57	-57	-60	294	76	-44	-59	-1	14
Net Cash Flow from Financing Activities	-63	-102	-83	-78	93	26	-101	-115	-131	235	18	-122	-232	-103	-108
Free Cash Flow to Equity	74	131	126	67	87	161	211	429	49	-15	-63	253	-202	67	169
Free Operating CF net dividend	85	180	149	76	-86	54	222	429	38	-371	-200	223	-317	-38	38
Free Operating CF	111	206	179	110	-46	93	267	487	109	-312	-141	296	-144	64	155

Business Segment Analysis

FY End:

Mar 25

Gujarat Alkalies And Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Chemicals (100.0%)₹ 325.45 Cr

Revenue / Sales

Chemicals (100.0%)₹ 4,072.91 Cr

Assets

Chemicals (100.0%)₹ 7,986.63 Cr

Operating Income

Chemicals (100.0%)₹ -21.85 Cr

Regional Segment Analysis

Gujarat Alkalies And Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Gujarat Alkalies And Chemicals Ltd.

Historical Segment Analysis

Track how Gujarat Alkalies And Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
Chemicals	574	795	909	683	231	325

Frequently Asked Questions

What is the revenue of Gujarat Alkalies And Chemicals Ltd.?

The latest trailing twelve month revenue of Gujarat Alkalies And Chemicals Ltd. is ₹ 4,497.87 Cr, reflecting a 1-year growth of 7.07% and a 3-year CAGR of 1.50%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Gujarat Alkalies And Chemicals Ltd.?

The latest trailing twelve month net profit (PAT) of Gujarat Alkalies And Chemicals Ltd. is ₹ 66.35 Cr, with a 3-year earnings CAGR of -25.66%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Gujarat Alkalies And Chemicals Ltd.?

The trailing twelve month EBITDA of Gujarat Alkalies And Chemicals Ltd. is approximately ₹ 94.53 Cr (based on an operating margin of 2.10%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Gujarat Alkalies And Chemicals Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Gujarat Alkalies And Chemicals Ltd. is 9.04. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Gujarat Alkalies And Chemicals Ltd.?

The debt-to-equity ratio of Gujarat Alkalies And Chemicals Ltd. stands at 0.11. The interest coverage ratio is 1.44x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Gujarat Alkalies And Chemicals Ltd.?

The estimated book value per share of Gujarat Alkalies And Chemicals Ltd. is 700.19 (derived from a P/B ratio of 1.03 and market price of ₹ 719.85), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Gujarat Alkalies And Chemicals Ltd.?

The trailing twelve month operating cash flow of Gujarat Alkalies And Chemicals Ltd. is ₹ 413.11 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Gujarat Alkalies And Chemicals Ltd. report consolidated or standalone financials?

Gujarat Alkalies And Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.